Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Top News
Top News
Politics

Rep. Raúl Grijalva Diagnosed With Cancer, Continues Working

Raúl Grijalva during speech

Arizona Congressman Raúl Grijalva, the dean of Arizona's congressional delegation, made a public announcement on Tuesday regarding his health. The 76-year-old Democrat disclosed that he has been diagnosed with cancer after seeking medical treatment for a persistent cough that was initially thought to be pneumonia.

Grijalva expressed his determination to continue working while undergoing treatment, stating, 'This diagnosis has been difficult to process, but I am confident in the vigorous course of treatment that my medical team has developed, and I’ve begun my journey to fight this cancer.'

Although the specific type of cancer has not been disclosed, Grijalva's office confirmed that he has started treatment and is focused on his recovery. The congressman, who has served in the U.S. House since 2002, emphasized his commitment to regaining his health and returning to his duties as soon as possible.

Colleagues and constituents have shown an outpouring of support for Grijalva since the announcement, sending well wishes and encouragement for his recovery. The congressman's dedication to his constituents and his work in Congress has been widely recognized throughout his tenure.

As Grijalva navigates this challenging time, he remains optimistic about his prognosis and is determined to overcome this health obstacle. He expressed gratitude for the support he has received and reiterated his commitment to resuming his responsibilities once he has regained his health.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.